Combination of Hypothermia and Thrombectomy in Acute Stroke
- Sponsor
- University of Freiburg
- Study ID
- NCT06301412
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Endovascular Treatment
- Ischemic Stroke
- Large Vessel Occlusion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- hypothermia — DEVICEhypothermia is started after intubation for endovascular treatment and induced by transnasal cooling (RhinoChill) to a target temperature of 35°C and hypothermia is then maintained at 35°C for 6 hours after recanalisation by surface cooling followed by slow rewarming by 0.2°C per hour to 36.5°C
Study Details
The goal of this clinical trial is to test the combination of hypothermia and endovascular treatment in acute stroke patients with large vessel occlusion. The main question it aims to answer is: does an additional cooling to 35°C result in a benefit on clinical outcome ? Participants receive immediate cooling using a noninvasive transnasal cooling technique (RhonoChill) and are maintained at 35°C for 6 hours after reopening of the vessel using surface cooling, and then slowly rewarmed. Researchers will compare the intervention group (hypothermia and endovascular treatment and best medical treatment including iv thrombolysis) and control group (only endovascular treatment and best medical treatment including iv thrombolysis) to see if additional hypothermia leads to a better outcome after 3 months without relevant complications.
Key Dates
- Start date
- Jul 7, 2024
- Status verified
- Jan 2025
- Primary completion
- Mar 18, 2026
- Completion
- Jun 18, 2026
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: EVT groupstandard endovascular treatment (EVT) for large vessel occlusion (LVO) without hypothermia
- Active Comparator: EVT group plus hypothermia groupstandard endovascular treatment (EVT) for large vessel occlusion (LVO) combined with hypothermia
Primary Outcome Measure
functional outcome [ Time Frame: 3 months ]
Central Contacts
- Juergen Bardutzky, Prof.+49-15237729739
- Wolf-Dirk Niesen, PD Dr.0049-761-270-53050
Related Studies
- Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular DisordersRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Verapamil for Neuroprotection in StrokePHASE1/PHASE2 · Recruiting · Global Neurosciences Institute · Atlantic City, New Jersey
- The Recovery in Stroke Using PAP StudyRecruiting · Yale University · New Haven, Connecticut